Immediate Impact
3 standout
Citing Papers
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue
2023 Standout
Risk Factors and Biomarkers for Immune-Related Adverse Events: A Practical Guide to Identifying High-Risk Patients and Rechallenging Immune Checkpoint Inhibitors
2022 Standout
Works of Anas Hamad being referenced
Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic Review
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Anas Hamad | 36 | 66 | 45 | 42 | 52 | 237 | |
| John Coutsouvelis | 44 | 77 | 42 | 22 | 36 | 290 | |
| Gholamreza Bahoush | 77 | 47 | 12 | 30 | 40 | 256 | |
| Philippe Fagnoni | 30 | 59 | 15 | 14 | 34 | 280 | |
| Randall W. Knoebel | 41 | 55 | 17 | 9 | 35 | 296 | |
| Amélie Cransac | 25 | 21 | 17 | 34 | 24 | 132 | |
| Katie S. Gatwood | 78 | 104 | 29 | 6 | 31 | 237 | |
| Henry H. L. Wu | 11 | 20 | 17 | 11 | 57 | 241 | |
| Marc Earl | 59 | 129 | 10 | 10 | 24 | 269 | |
| Samuel Gluck | 53 | 20 | 15 | 10 | 42 | 293 | |
| Arnaud Pagès | 10 | 20 | 44 | 5 | 41 | 209 |
All Works
Login with ORCID to disown or claim papers
Loading papers...